February 10, 2016 – 
The Final AMP Rule was released in January after a four-year wait with an effective date of April 1, 2016.  This rule will have a number of implications for the 340B program, and 340B Health recently conducted a webinar to address this impact.  Here are links to their slide presentation and video recording. To request a copy of the PowerPoint slides and AV recording, email karen.morten@phvne.com or for more information go to https://www.federalregister.gov/articles/2016/02/01/2016-01274/medicaid-program-covered-outpatient-drugs